Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Calcipotriol

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Daivonex

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LEO Pharma Wins China NMPA Approval for Enstilar Psoriasis
    LEO Pharma Wins China NMPA Approval for Enstilar Psoriasis

    17 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260417015768/en/LEO-Pharma-expands-its-psoriasis-portfolio-in-China-with-NMPA-approval-of-Enstilar

    BUSINESSWIRE
    17 Apr 2026
    Share Share
    How Traders Can Ensure Safe Export of Calcipotriol Monohydrate
    How Traders Can Ensure Safe Export of Calcipotriol Monohydrate

    04 Dec 2025

    // PRESS RELEASE

    https://www.centurypharma.com/how-traders-can-ensure-safe-of-calcipotriol-monohydrate/

    PRESS RELEASE
    04 Dec 2025
    Share Share
    SKNV Launches Kefunova, Custom 5-FU Medication
    SKNV Launches Kefunova, Custom 5-FU Medication

    30 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sknv-launches-kefunova-a-custom-formulated-5-fu-prescription-medication-302441877.html

    PR NEWSWIRE
    30 Apr 2025
    Share Share
    Endo Partners Paladin Pharma to Commercialize Wynzora in Canada
    Endo Partners Paladin Pharma to Commercialize Wynzora in Canada

    15 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endo-announces-agreement-for-paladin-pharma-to-commercialize-wynzora-cream-in-canada-302306565.html

    PR NEWSWIRE
    15 Nov 2024
    Share Share
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Glenmark gets USFDA nod for generic drug with 180-day exclusivity
    Glenmark gets USFDA nod for generic drug with 180-day exclusivity

    23 Mar 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-for-generic-drug-with-180-day-exclusivity/articleshow/98934035.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    23 Mar 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.